Ep 289 - Refractory VF, Double Sequential Defibrillation, and the Future of Cardiac Arrest

What do we really know about treating refractory ventricular fibrillation?And why are we still waiting to use strategies that might actually work?

In this episode, we talk to Sheldon Cheskes about the evolving science of cardiac arrest, with a focus on refractory and recurrent ventricular fibrillation. We explore the evidence behind double sequential external defibrillation (DSED), how it compares to standard defibrillation, and what the DOSE VF trial has changed in practice.

This is not just about adding another shock.It’s about understanding why defibrillation fails, how vector and energy delivery matter, and when a different approach might improve outcomes.

We also discuss:

The difference between refractory and recurrent VF — and why it matters

What DSED and vector change actually do in physiological terms

Why guidelines have been slow to move despite emerging evidence

The role of antiarrhythmics, adrenaline, and sequence of care

Practical considerations for introducing DSED into real systems

What comes next — from smarter detection to post-arrest recovery

This is a conversation grounded in real-world resuscitation.It challenges current practice without overselling the evidence.

Key Learning Points